[1]
Abdulraheem Mohamed A et al. 2026. Development and in Vitro Evaluation of CRISPR-Cas9-Engineered CAR-NK Cells Targeting Solid Tumors. American Journal of Biodiversity. 3, 4 (Apr. 2026), 41–48. DOI:https://doi.org/10.51699/ajb.v3i4.2268.